Cancer Diagnostics & Biomarkers
Part of Healthcare - Oncology
 NTRA | Natera, Inc. Common Stock | $59.1b | $402.98 | +0.2% | 728.2K |
 GH | Guardant Health, Inc. Common Stock | $23.9b | $171.62 | +2.5% | 1.8M |
 CAI | Caris Life Sciences, Inc. Common Stock | $8.0b | $32.66 | +1.4% | 1.7M |
 GRAL | GRAIL, Inc. Common Stock | $6.4b | $141.34 | +5.7% | 652.9K |
 BLLN | BillionToOne, Inc. Class A Common Stock | $5.0b | $111.44 | +3.2% | 369.4K |
 ADPT | Adaptive Biotechnologies Corporation Common Stock | $4.5b | $24.96 | +3.0% | 901.1K |
 VCYT | Veracyte, Inc. | $3.7b | $48.18 | +0.6% | 505.5K |
 NEO | NeoGenomics, Inc. | $2.4b | $16.68 | +0.6% | 1.0M |
 PSNL | Personalis, Inc. Common Stock | $1.7b | $15.88 | +0.3% | 869.5K |
 CSTL | Castle Biosciences, Inc. Common Stock | $1.1b | $33.29 | +0.5% | 173.5K |
 ANGO | AngioDynamics, Inc. | $0.6b | $12.18 | -1.5% | 340.8K |
 FLGT | Fulgent Genetics, Inc. Common Stock | $0.6b | $20.23 | +0.8% | 159.7K |
 TOI | The Oncology Institute, Inc. Common Stock | $0.5b | $5.19 | 0.0% | N/A |
 MYGN | Myriad Genetics Inc | $434.2m | $5.99 | +3.4% | 1.3M |
 BDSX | Biodesix, Inc. Common Stock | $292.5m | $21.29 | +0.3% | 55.7K |
 LUCD | Lucid Diagnostics Inc. Common Stock | $119.8m | $0.53 | +23.6% | 42.3M |
 QUCY | Quantum Cyber N.V. Ordinary Shares | $111.8m | $0.90 | -13.3% | 575.7K |
 MDXH | MDxHealth SA Ordinary Shares | $54.5m | $0.19 | +4.6% | 839.7K |
 SRTS | Sensus Healthcare, Inc | $49.1m | $2.82 | 0.0% | 18.6K |
 PRPO | Precipio, Inc. Common Stock | $41.4m | $19.30 | -2.7% | 33.1K |
 PAVM | PAVmed Inc. Common Stock | $22.9m | $2.25 | 0.0% | 4.3K |
 ADVB | Advanced Biomed Inc. Common Stock | $11.1m | $2.91 | 0.0% | 11.3K |
 ZCMD | Zhongchao Inc. Class A Ordinary Shares | $8.2m | $1.22 | -6.2% | 54.5K |
 VNRX | VolitionRx Limited | $7.1m | $0.19 | +3.4% | 540.9K |
 AIDX | 20/20 Biolabs, Inc. Common Stock | $4.9m | $0.24 | 0.0% | 24.5K |
 BIAF | bioAffinity Technologies, Inc. Common Stock | $3.6m | $2.85 | +1.4% | 68.0K |
 ALBT | Avalon GloboCare Corp. Common Stock | $3.5m | $0.28 | 0.0% | N/A |
 ONCO | Onconetix, Inc. Common Stock | $3.2m | $0.33 | -4.9% | 446.4K |